NCT03586037View on ClinicalTrials.gov

Evaluating the Pharmacokinetic Interaction Between AD-2011 and AD-2012

PHASE1CompletedINTERVENTIONAL
Enrollment

36

Participants

Timeline

Start Date

June 12, 2018

Primary Completion Date

August 9, 2018

Study Completion Date

August 20, 2018

Conditions
HyperlipidemiasHypertension
Interventions
DRUG

AD-2011 10/20 mg

AD-2011 10/20 mg tablet

DRUG

AD-2012 80mg

AD-2012 80mg tablet

DRUG

AD-2011 10/20 mg + AD-2012 80mg

AD-2011 10/20 mg + AD-2012 80mg tablet

Trial Locations (1)

Unknown

Seoul National University Hospital, Seoul

All Listed Sponsors
lead

Addpharma Inc.

INDUSTRY

NCT03586037 - Evaluating the Pharmacokinetic Interaction Between AD-2011 and AD-2012 | Biotech Hunter | Biotech Hunter